By otakuyassine3@gmail.com 
Principal Financial Group Inc. trimmed its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 141,083 shares of the company’s stock after selling 4,752 shares during the period. Principal Financial Group Inc.’s holdings in Henry Schein were worth $9,763,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Allworth Financial LP grew its holdings in shares of Henry Schein by 180.7% during the fourth quarter. Allworth Financial LP now owns 946 shares of the company’s stock valued at $71,000 after buying an additional 609 shares during the last quarter. Figure 8 Investment Strategies LLC bought a new position in Henry Schein in the 4th quarter valued at approximately $538,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in Henry Schein during the 4th quarter valued at $2,281,000. Quent Capital LLC increased its holdings in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares in the last quarter. Finally, Equitable Trust Co. purchased a new position in shares of Henry Schein in the fourth quarter worth $417,000. 96.62% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several research firms recently commented on HSIC. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a report on Wednesday. UBS Group decreased their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday. Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Finally, Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $81.10.
View Our Latest Research Report on HSIC
Henry Schein Trading Up 0.1 %
NASDAQ:HSIC opened at $72.17 on Friday. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.49. The business has a fifty day moving average price of $74.35 and a 200-day moving average price of $72.42. The firm has a market capitalization of $9.00 billion, a price-to-earnings ratio of 29.70, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the previous year, the company earned $0.66 EPS. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. Sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Stories
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Henry Schein and related companies with MarketBeat.com’s FREE daily email newsletter.